AnalystsRobert DriscollRobert Driscoll's Stock Forecasts
AnalystsRobert Driscoll
Sectors:
Industries:
Analyst Ranking
Top 7%
#376 out of 5497 analysts
Average Return
+14.28%
Win Rate
45%96 out of 215
Risk vs Reward
Poor
Good
Robert Driscoll's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Janux Therapeutics IncJANX | +718.88% | $6.62 | $54.21 | 2023-11-08 - 2024-11-07 | Buy |
Five Prime Therapeutics IncFPRX | +494.68% | $6.39 | $38.00 | 2020-06-22 - 2021-04-15 | Buy |
Alpine Immune Sciences IncALPN | +414.33% | $12.63 | $64.96 | 2023-11-15 - 2024-05-16 | Buy |
Alpine Immune Sciences IncALPN | +403.57% | $12.90 | $64.96 | 2023-09-01 - 2024-05-16 | Buy |
Alpine Immune Sciences IncALPN | +381.19% | $13.50 | $64.96 | 2023-08-15 - 2024-05-16 | Buy |
Robert Driscoll Analyst Color
Get additional color on Robert Driscoll's coverage of popular stocks
Robert Driscoll's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Eikon Therapeutics IncEIKN | 4 | Sell | $4.00 | -64.88% | Maintains | 8 days ago |
Cullinan Therapeutics IncCGEM | 9 | Buy | $42.00 | +93.73% | Maintains | 9 days ago |
Kura Oncology IncKURA | 13 | Buy | $38.00 | +219.60% | Maintains | 9 days ago |
Aprea Therapeutics IncAPRE | 7 | Buy | $3.00 | +368.75% | Maintains | 9 days ago |
Replimune Group IncREPL | 12 | Buy | $19.00 | +28.64% | Upgrades | 15 days ago |
Revolution Medicines IncRVMD | 14 | Buy | $201.00 | -4.04% | Maintains | 16 days ago |
Arcus Biosciences IncRCUS | 9 | Buy | $43.00 | +41.73% | Maintains | 16 days ago |
Ideaya Biosciences IncIDYA | 15 | Buy | $60.00 | +51.25% | Maintains | 17 days ago |
Arvinas IncARVN | 9 | Hold | $12.00 | +28.14% | Maintains | 17 days ago |
Monte Rosa Therapeutics IncGLUE | 5 | Buy | $27.00 | +88.81% | Maintains | 19 days ago |
Corbus Pharmaceuticals Holdings IncCRBP | 3 | Buy | $30.00 | +189.02% | Maintains | 3 months ago |
Tango Therapeutics IncTNGX | 6 | Buy | $33.00 | +38.19% | Maintains | 3 months ago |
Avalo Therapeutics IncAVTX | 2 | Buy | $34.00 | +71.46% | Maintains | 3 months ago |
Janux Therapeutics IncJANX | 8 | Buy | $36.00 | +107.02% | Maintains | 3 months ago |
Pyxis Oncology IncPYXS | 1 | Buy | $6.00 | +94.81% | Initiates Coverage On | 4 months ago |
Black Diamond Therapeutics IncBDTX | 10 | Buy | $14.00 | +533.48% | Maintains | 5 months ago |
Cytomx Therapeutics IncCTMX | 8 | Buy | $11.00 | +235.37% | Maintains | 5 months ago |
Foghorn Therapeutics IncFHTX | 6 | Buy | $10.00 | +41.44% | Reiterates | 5 months ago |
Day One Biopharmaceuticals IncDAWN | 8 | Hold | $21.50 | -0.14% | Downgrades | 5 months ago |
Tyra Biosciences IncTYRA | 10 | Buy | $53.00 | +103.45% | Maintains | 6 months ago |
Cg Oncology IncCGON | 1 | Buy | $70.00 | -12.29% | Initiates Coverage On | 8 months ago |
Crescent Biopharma IncCBIO | 1 | Buy | $27.00 | N/A | Initiates Coverage On | a year ago |
Zentalis Pharmaceuticals IncZNTL | 11 | Hold | $4.00 | N/A | Reiterates | a year ago |
Werewolf Therapeutics IncHOWL | 3 | Buy | $6.00 | N/A | Maintains | a year ago |
Igm Biosciences IncIGMS | 9 | Buy | $22.00 | N/A | Maintains | 2 years ago |
Adicet Bio IncACET | 8 | Buy | $80.00 | N/A | Reiterates | 2 years ago |
Omega Therapeutics IncOMGAQ | 4 | Buy | $12.00 | N/A | Reiterates | 2 years ago |
Compass Therapeutics IncCMPX | 2 | Buy | $8.00 | N/A | Reiterates | 2 years ago |
Geron CorpGERN | 8 | Buy | $7.00 | N/A | Reiterates | 2 years ago |
Alpine Immune Sciences IncALPN | 8 | Hold | $65.00 | N/A | Reiterates | 2 years ago |
Elevation Oncology IncELEV | 7 | Buy | $8.00 | N/A | Reiterates | 2 years ago |
Atreca IncBCEL | 4 | Hold | $1.00 | N/A | Downgrades | 3 years ago |
Surface Oncology IncSURF | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Cyteir Therapeutics IncCYTT | 3 | Buy | $3.00 | N/A | Reiterates | 3 years ago |
Imago Biosciences IncIMGO | 2 | Hold | $36.00 | N/A | Downgrades | 4 years ago |
Harpoon Therapeutics IncHARP | 4 | Buy | $70.00 | N/A | Upgrades | 4 years ago |
Entasis Therapeutics Holdings IncETTX | 1 | Hold | $1.80 | N/A | Downgrades | 4 years ago |
Aceragen IncACGN | 2 | Hold | $1.00 | N/A | Downgrades | 5 years ago |
Five Prime Therapeutics IncFPRX | 4 | Buy | $9.00 | N/A | Upgrades | 6 years ago |
Arbutus Biopharma CorpABUS | 4 | Buy | $4.00 | N/A | Upgrades | 6 years ago |
Nabriva Therapeutics PLCNBRVF | 1 | Hold | $250.00 | N/A | Downgrades | 6 years ago |
Paratek Pharmaceuticals IncPRTK | 1 | Buy | $34.00 | N/A | Reiterates | 9 years ago |
Sierra Oncology IncSRRA | 1 | Buy | $4.00 | N/A | Upgrades | 10 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.